H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 6.1% of adults in Seattle have diagnosed diabetes — 5.9 points below the U.S. 12% figure. Census population 749,256. Washington Medicare wound biologics: Noridian Healthcare Solutions (JF). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Seattle clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Seattle storefront.
Growth Factor Therapy for Tissue Repair in Seattle, WA for clinics & physicians. Growth factor therapy pro… Compliance support & pricing — contact Hawk Medical.
Adult obesity in Seattle is 22.2% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. CDC PLACES (2023, crude) estimates 6.1% of adults in Seattle have diagnosed diabetes — 5.9 points below the U.S. 12% figure. Washington is outside CDC’s core Diabetes Belt list; use the PLACES city rate anyway. Hawk Medical is the distributor for growth factor therapy, not a walk-in clinic.
National Growth Factor Therapy for Tissue Repair notes (how the product actually works)JF reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Seattle is 6.1% or not. PLACES is planning data. The LCD is the claim.
We are not going to invent a Seattle warehouse or a five-star local review. What you get is growth factor therapy from FDA-registered sources, lot paperwork, and someone who has run the same SOPs in clinic — Joe Bradley. The local numbers on this page are CDC PLACES and CMS JF, not marketing adjectives.
CDC PLACES (2023, crude prevalence) estimates 6.1% of adults — 5.9 points below the U.S. 12% figure. Obesity is 22.2%; arthritis is 17%. That is place-level BRFSS modeling, not a clinic census and not a Seattle trial.
We source from FDA-registered banks. Bank location is not the same as Hawk Medical’s distribution address, and it is not a Seattle clinic. Ask for the bank’s registration and AATB status on the SKU you want.
Joe Bradley, Founder & CEO of Hawk Medical LLC, is an active clinical practice owner. These programmatic pages are distribution resources for providers, reviewed against the same HCT/P and wound-care portfolio used in that practice. They are not patient treatment advice.
We distribute nationwide. Transit time depends on carrier and SKU, not on a fictional local warehouse. Ask for current lead times on the specific centrifuge, allograft, or CTP you intend to bill.
If you operate in Washington and another MAC state, say it on the first call. JF will not port 1:1. We would rather split utilization than watch a sister clinic copy Seattle tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Seattle, WA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Seattle is JF geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Seattle — 5.9 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Washington Part B wound biologics follow this contractor (siblings: AK, AZ, ID, MT, ND, OR, SD, UT, WY). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Seattle. Useful for joint-program math; still needs a diagnosis and privileging.
No Seattle storefront. Joe Bradley is an active practice owner. growth factor therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.